Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
"Now, with PanOptix Pro, more light utilization and less light scatter is possible‡,‡‡, empowering both my practice and my patients.'
Share
'As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D,' said Rob Scott, VP, Intraocular Devices, R&D, Alcon. 'Our team looked at hundreds of design options, ultimately landing on a targeted diffractive refinement that helped us recover 50% of light lost to scatter, and reposition it to a beneficial focal point for PanOptix Pro. 1,3,10.14-19,* This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world's most implanted trifocal IOL.' 1-3,20,21,*,**,‡‡,‖,Ω
'PanOptix has been a cornerstone of my cataract practice for eight years,' said Dr. Rosa Braga-Mele, MD, MEd, FRCSC, Professor of Ophthalmology, University of Toronto. 'These lenses have consistently delivered outstanding visual outcomes for my patients 10, 24, § – a low visual disturbance profile 25, ∂ and a happy patient with greater spectacle independence. 23, § So, it's exciting to see this technology evolve to further meet patients' visual expectations. Now, with PanOptix Pro, more light utilization and less light scatter is possible ‡,‡‡, empowering both my practice and my patients.'
PanOptix Pro will be available in Canada from Alcon in the single-use Clareon AutonoMe ® preloaded delivery system and as well as with the Clareon Monarch ® IV delivery system in early 2026. 22 PanOptix Pro offers a +2.17 diopter intermediate and a +3.25 diopter near add power. Like all Alcon IOLs, PanOptix Pro will be available with blue light and ultraviolet filtering. 22
For surgeons interested in more information on PanOptix Pro, please speak to a local Alcon representative.
About Clareon PanOptix Pro
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the center of the Clareon PanOptix Pro Trifocal IOL allows for better near (reading) vision and intermediate (computer work) vision versus what a monofocal lens would provide. Please consult the Directions for Use regarding indications, precautions, cautions and warnings which is available at ifu.alcon.com.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca.
* PanOptix has 88% light utilization (12% scatter light)/PanOptix Pro 94% light utilization (6% scatter light).
** Based on manufacturer-reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.
† For feasible diffractive optics of up to pentafocal design from Krackhardt et al.
†† Simulated photopic through-focus point spread function (light intensity [energy])—polychromatic.
‡ Compared to Clareon PanOptix.
‡‡ Based on bench and vision simulator studies.
§Based on prospective multicenter randomized study at 6 months, significantly more subjects reported not experiencing starburst and glare (p<0.05 n=276).
§§All-implanted analysis set.
¶In response to the IOLSAT questionnaire question 'In the past 7 days, how often did you need to wear eyeglasses to see'?
¶¶Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op "Given your vision today, if you had to do it all over, would you have the same lenses implanted again?"; n=127.
‖ Based on worldwide IOL unit sales of Clareon PanOptix and AcrySof IQ PanOptix through Q1, 2024.
Ω Severity ratings by phakic patients with simulated implant of Clareon PanOptix Pro and Clareon PanOptix using VirtIOL simulator (n=64).
∂ Based in a meta-analysis of 11 unique clinical studies with 580 patients in 10 different countries, including "very bothersome' and "severe" visual disturbances. Clinical studies were performed on the AcrySof IQ PanOptix IOL; AcrySof IQ PanOptix and Clareon PanOptix are optically equivalent.
Expand
References
Alcon data on file, 2025. REF-25218
Alcon data on file, 2024. REF-25221
Alcon data on file, 2015. REF-08546
Krackhardt U, et al: Upper bound on the diffraction efficiency of phase-only fanout elements. Applied Optics; 1992; 31:27-37.; 10. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston.
Rayner Professional Website. https://rayner.com/en/iol/trifocal/rayone-trifocal/. Accessed September 2024.
Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53.
ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014.
Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe.ophthalmologytimes.com/zeiss-cataract-insight-series?page=1. Accessed September 2024.
Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clinical Ophthalmology. 2023;Volume 17:155-163. doi:10.2147/opth.s377234.
Alcon data on file, 2024. REF-23958.
Alcon data on file, 2018. REF-01475.
Alcon Vision LLC. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information. 2021.
Charness N, Dijkstra K, Jastrzembski T, Weaver S, Champion M. Monitor viewing distance for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008;52(19):1614- 1617. doi:10.1177/154193120805201965
Government of Canada CC for OH and S. CCOHS: Office ergonomics. Canadian Centre for Occupational Health and Safety. April 25, 2023. Accessed May 9, 2023. https://www.ccohs.ca/oshanswers/ergonomics/office/.
Gundersen K, Potvin R. Trifocal intraocular lenses: A comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology. 2017;Volume 11:1081-1087. doi:10.2147/opth.s136164
Kohnen T, Titke C, Böhm M. Trifocal intraocular lens implantation to treat visual demands in various distances following lens removal. American Journal of Ophthalmology. 2016;161. doi:10.1016/j.ajo.2015.09.030
Lwowski C, Pawlowicz K, Petermann K, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive extended depth-of-focus and trifocal intraocular lenses. Journal of Cataract and Refractive Surgery. 2022;48(4):421-428. doi:10.1097/j.jcrs.0000000000000780
Alcon data on file, 2024. REF-25903
Alcon data on file, 2024. REF-23554
MarketScope LLC. 2023 IOL Market Report: Global Analysis for 2022 to 2028. St. Louis, MO: MarketScope LLC; 2023.
Clareon® PanOptix® Pro Trifocal Hydrophobic Acrylic IOL Model PXYWT0 2024 Directions for Use.
Zhu D, et al. Rate of complete spectacle independence with a trifocal intraocular lens: A systematic literature review and meta-analysis. Ophthalmology and Therapy. 2023;12(2):1157-1171. doi:10.1007/s40123-023-00657-5.Alcon Vision LLC.
Modi S, Lehmann R, Maxwell A, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207. doi:10.1016/j.ophtha.2020.07.015
Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Coach Parent Warns Of Tariff Pressure Despite Strong Performance
Tapestry, Inc. (NYSE:TPR) stock tumbled in premarket trading Thursday despite topping Wall Street forecasts for the fourth quarter, fueled by double-digit revenue growth at its flagship Coach brand. The parent of Coach and Kate Spade posted adjusted earnings of $1.04 per share, ahead of the $1.02 consensus, on revenue of $1.72 billion, up 8% year-over-year and above expectations. Coach saw strong handbag revenue growth, driven by a mid-teens AUR gain for the quarter and a low-double-digit gain for the year. This reflects compelling innovation and broad-based traction across its leather goods overall revenue growth was led by a 14% (+13% constant currency) gain at the Coach Brand with $1.425 billion in revenues. Kate Spade revenues fell 13% to $252.6 million. Gross profit rose to $1.32 billion from $1.19 billion a year ago. Gross margin increased to 76.3% from 74.9%, driven by about 200 basis points of operational improvements, partly offset by a currency headwind of over 50 basis points. Cash, equivalents, and short-term investments totaled $1.12 billion, while total borrowings stood at $2.39 billion. This resulted in net debt of $1.27 billion. View more earnings on TPR Inventory was $861 million, as expected, which excluded $92 million of Stuart Weitzman inventory classified as Assets held for sale. Dividend The firm approved a 14% increase to the company's dividend, with a quarterly cash dividend of 40 cents per common share payable on September 22 to shareholders of record as of the close of business on September 5. 'We achieved bold targets we set three years ago in a dynamic landscape, delivering over $5 in adjusted earnings per share and returning more than $3 billion cumulatively to shareholders,' said CEO Joanne Crevoiserat. Outlook For fiscal 2026, Tapestry expects revenue to approach $7.2 billion compared to the $6.96 billion estimate, reflecting low-single-digit growth from last year. Excluding the planned divestiture of Stuart Weitzman, pro-forma sales are projected to rise at a mid-single-digit pace on both a nominal and constant-currency basis, with foreign exchange providing an 80-basis-point boost. Operating margin is forecast to improve by more than 250 basis points, though this will be largely offset by an estimated 230-basis-point drag from incremental tariffs and duties, a $160 million impact tied to policy changes, sell-through timing, and mitigation efforts. The company aims to fully offset these costs over time. Management projects net interest expense of about $65 million, an effective tax rate of roughly 18%, and a weighted average diluted share count near 213 million. Adjusted EPS is guided at $5.30-$5.45, up 4%-7% year-over-year, despite more than 60 cents in negative tariff and duty effects. Adjusted free cash flow is expected to approach $1.3 billion. Price Action: TPR shares are trading lower by 12.36% to $99.50 premarket at last check Thursday. Read Next:Image via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Coach Parent Warns Of Tariff Pressure Despite Strong Performance originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Business Wire
15 minutes ago
- Business Wire
Ambiq Micro to Announce Second Quarter 2025 Financial Results on September 4, 2025
AUSTIN, Texas--(BUSINESS WIRE)-- Ambiq Micro, Inc. (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, will release its second quarter 2025 financial results on Thursday, September 4, 2025 after market close. Fumihide Esaka, Chief Executive Officer, and Jeff Winzeler, Chief Financial Officer, will host a conference call at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) to discuss its results. Analysts and investors are invited to join the live conference call using the following information: Date: Time: 3:30 p.m. Central Time (4:30 p.m. Eastern Time) Conference Call Number: 1-800-715-9871 International Call Number: +1-646-307-1963 Pass code: 3633496 Additionally, this conference call will be broadcast live over the Internet and can be accessed by all interested parties on the Events & Presentations section of the Company's Investor Relations website. For those unable to participate during the live broadcast of the conference call, a telephone replay of the conference call will be available approximately two hours after the conference call and accessible through September 11, 2025. The replay dial-in number is 1-800-770-2030, and the pass code 3633496. International callers should dial +1-647-362-9199 and enter the same pass code. Additionally, a replay of the webcast will be available on Ambiq's Investor Relations website for approximately 90 days. About Ambiq Ambiq's mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Ambiq enables its customers to deliver AI compute at the edge where power consumption challenges are the most severe. Ambiq's technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT®), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. Ambiq has powered over 270 million devices to date. For more information, visit
Business Wire
15 minutes ago
- Business Wire
O'Reilly Achieves Workday Certified Integration and Joins the Workday Marketplace to Support Workforces in Building Critical Tech and Business Skills
BOSTON--(BUSINESS WIRE)-- O'Reilly Media, Inc., a premier learning platform for technology professionals, today announced that it has achieved Workday Certified Integration status. O'Reilly provides its customers with a seamless integration that connects Workday Learning with the O'Reilly learning platform. O'Reilly's cutting-edge content is now able to be integrated with Workday Learning, enabling teams to bridge their skill gaps and stay ahead of rapidly evolving technology and business trends. Learners gain access to over 70,000 resources, including books, courses, hands-on labs, and expert-led live training, all within their familiar Workday environment. Automatic synchronization provides learners with access to the most up-to-date materials. Retired content is seamlessly removed — no manual updates required. 'We are excited to partner with Workday to help transform organizations' learning experiences by bringing O'Reilly's comprehensive tech and business expertise directly into Workday Learning,' said Julie Baron, chief product officer at O'Reilly. 'This integration eliminates the friction between learning and application while maximizing organizations' existing L&D investments.' More information on O'Reilly's integration can be found on the Workday Marketplace, which provides easy access to solutions built by Workday and its partners. About O'Reilly O'Reilly, the premier learning platform for technology professionals, offers the industry's most extensive catalog of high-quality technical and professional skills development courses. From AI, programming and cloud technologies to essential business skills such as leadership training and critical thinking, O'Reilly delivers highly trusted content from its network of renowned experts that meets a diverse array of learning needs, with over 5,000 role-based on-demand courses, nearly 200 live events each month, access to interactive sandboxes and labs and more. For more information, visit
